Answers are grounded in this paper and cite their sources.
Analysis reveals significant inhibitory activity of hibiscus extracts on α-glucosidase and α-amylase, implying potential benefits for diabetes management.
Hibiscus rosa-sinensis flowers had traditionally been used in folk medicine to manage diabetes; however, the mechanisms underlying their glucose-lowering effects remained unclear. The aim of this study was to investigate phytochemical properties and in vitro inhibitory activity of Hibiscus rosa-sinensis flower extracts on starch-hydrolyzing enzymes. Ethanol (70 %) and aqueous extracts (EE and AE respectively) were prepared using an ultrasound-assisted extraction method. The phytochemical properties of the extracts were determined by colorimetric reactions. The antidiabetic activity of these extracts was examined via α-glucosidase and α-amylase inhibitory assays. The extracts were found to contain bioactive phytochemicals, including flavonoids, mucilage, tannins and reducing compounds. Moreover, the inhibitory effect of aqueous and ethanol 70 % extracts on α-glucosidase activity was observed at IC50 values of 1.40 ± 0.02 mg/mL and 0.92 ± 0.02 mg/mL, respectively. On the other hand, α-amylase activity was also inhibited by aqueous extract and ethanol 70 % extract at IC50 values of 1.39 ± 0.09 mg/mL and 0.95 ± 0.06 mg/mL, respectively. These findings suggested that the inhibitory activity of H. rosa-sinensis flower extracts on α-glucosidase and α-amylase might have contributed to the reduction of blood glucose levels, indicating potential for diabetes management.
No takes yet. Share an insight, caveat, or question.
Mỹ et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: